OR WAIT null SECS
October 15, 2020
The judges chose Sheng from a shortlist of seven candidates and highlighted his work in the Taiwanese and global markets while guiding the company through “pivotal changes” that demonstrated his abilities as a “top CEO.”
Cytiva will provide the first FlexFactory to be used in the manufacture of pDNA to Akron Bio.
The approval comes after a Phase III trial that showed Keytruda reduced the risk of disease progression or death by 35%.
October 14, 2020
Shimadzu, has opened a new branch office in Copenhagen, Denmark.
Cambrex has completed the expansion of its solid form screening and crystallization process development facility in Edinburgh, Scotland.
Oxular has been granted rare pediatric disease and orphan drug designations by the US FDA for its proprietary drug, OXU-003.
The UK's MHRA has joined the Australia-Canada-Singapore-Switzerland (ACSS) Consortium of regulators.
Recent data, from BIA and Clarivate, has revealed that investment in UK biotech continues to be strong.
Roche will use Dyno’s CapsidMap platform to develop next-generation adeno-associated virus vectors for gene therapies for central nervous system diseases and liver-directed therapies.
October 13, 2020
The winners were announced during day seven of CPhI Festival of Pharma.
